loader2
Partner With Us NRI

Company details

30.55
33.70
19.50
39.35
6M Return 4.68%
1Y Return -1.26%
Mkt Cap.(Cr) 27.37
Volume 2,831
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 2,831

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 26.76 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 7,209.51 3,450.07
LAST 3M 8,638.44 51,120.10
LAST 6M 84,196.20 -58,438.16
LAST 12M 204,915.33 -198,833.91

Information

  • About Company
  • Company Info
  • Listing Info
25.72
49%
32.4389
5.01%
1.59%
Description
  • CONCORD DRUGS LIMITED is a public limited company established in 1995, is among the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small volume parenterals, Dry powder ) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality. The company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide our customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing. The company operates a state of the art, cGMP contract manufacturing Formulation-Fill-Finish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products. The company has two manufacturing facilities built to comply with standards stipulated by Regulatory bodies.

Read More

Registered Address

Survey No 249 Brahmanapally V, Hayathnagar M, Ranga Reddy, Telangana, 501511

Tel : 91-40-24036379
Email : concorddrugsltd:gmail.com
Website : http://www.concorddrugs.in

Registrar

Aarthi Consultants Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 538965
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : X
ISIN : INE858L01010

ICICIdirect Concord Drugs Ltd FAQ

You can buy Concord Drugs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Concord Drugs Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Sep 28, 2022 02:15 PM the closing price of Concord Drugs Ltd was ₹ 31.30.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Sep 28, 2022 02:15 PM, the market cap of Concord Drugs Ltd stood at ₹ 27.37.
The latest PE ratio of Concord Drugs Ltd as of Sep 28, 2022 02:15 PM is 25.72
The latest PB ratio of Concord Drugs Ltd as of Sep 28, 2022 02:15 PM is 1.01
The 52-week high of Concord Drugs Ltd is ₹ 39.35 while the 52-week low is ₹ 19.50 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE